National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) (CMS-10639)

ICR 202207-0938-012

OMB: 0938-1340

Federal Form Document

ICR Details
0938-1340 202207-0938-012
Received in OIRA 202111-0938-005
HHS/CMS CCSQ
National Healthcare Safety Network (NHSN) Data Validation Study for the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) (CMS-10639)
Revision of a currently approved collection   No
Regular 07/19/2022
  Requested Previously Approved
36 Months From Approved 12/31/2024
6,000 6,000
1,500 1,500
0 0

For the PY 2025 study, CMS is continuing to use its previously finalized policy to select 300 facilities to participate in an NHSN Dialysis Event validation study by submitting a total of 20 patient records across any two quarters of data reported in CY 2023.

US Code: 42 USC 1395R Name of Law: End State Renal Disease
  
None

0938-AU79 Proposed rulemaking 87 FR 38464 06/28/2022

No

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,000 6,000 0 0 0 0
Annual Time Burden (Hours) 1,500 1,500 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$188,503
No
    No
    No
No
No
No
No
Denise King 410 786-1013 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/19/2022


© 2024 OMB.report | Privacy Policy